Tunisia: Scientific Study to Be Conducted to Assess Covid-19 Vaccines' Efficiency in Tunisia

Tunis/Tunisia — A scientific study will be conducted shortly to assess the efficiency of the COVID-19 vaccines used in Tunisia, Head of the Clinical Immunology Ward at the Pasteur Institute Malika Ben Ahmed said Thursday.

"This study will involve about 1 million Tunisians who have already been administered both doses, in a bid to assess the vaccines' efficiency," he pointed out to TAP, adding that Tunisia has used 5 different vaccines since the start of the national jab drive.

The COVID-19 vaccines, whatever the type of vaccine or its efficiency, minimises deaths and the risks of developing severe forms of the disease, calling on Tunisians to be massively vaccinated, especially after the delivery of large quantities of vaccines to Tunisia.

Given the spread of the new COVID-19 variant, the administration of a 3rd shot will be necessary, however, this operation is currently not feasible at present due to insufficient stock, Ben Ahmed indicated.

AllAfrica publishes around 800 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.